Home | Press Room | Site Map | e-supply | Türkçe


A well-established past since 1954

sep About Us
Management Systems
Press Room

TSE COVID-19 Safe Production Certificate

A‒  A+  print

PharmaVision - TSE COVID-19 Safe Production Certificate Process

Due to the COVID-19 epidemic experienced worldwide since the beginning of 2020, a new work order has been implemented in workplaces. The first case was seen in our country on March 10th, 2020 and COVID-19 was declared a global epidemic (pandemic) by the World Health Organization on March 11th, 2020. There is a risk of contamination of the virus, which spreads very rapidly, without any symptoms, and effective protection is provided by wearing face masks, social distancing and practicing good hygiene.

As a company, by pursing all the developments on a global scale very closely, in line with our traditional and comprehensive principles on employee health and business continuity, the necessary measures were taken at our workplace and the ongoing work is transparently shared with all our stakeholders thanks to the Crisis Committee formed on March 6th, 2020, before the first case was detected in our country and the pandemic announcement was made.

Under the leadership of the Senior Management and the Crisis Committee, thanks to our colleagues who approached the issue with sensitivity, a standardized and continuous system was established at our workplace with physical measures, special hygiene practices, intensive training within the scope of our pandemic prevention policy.

In accordance with our company philosophy, an application was made to the Turkish Standards Institute in order to obtain "TSE COVID-19 Safe Production Certificate", thus verifying and documenting the adequateness of the activities we carry out in this regard by an independent institution.

Upon our application, the Turkish Standards Institute (TSE) conducted one of the first inspections for this new certificate at our workplace.

The inspection, which accepts the measures specified in the 'COVID-19 Guide for Industrialists' as a minimum requirement, took place at our facilities on June 9th, 2020 and with the meeting decision dated 11.06.2020/07, the TSE Executive Committee entitled

PharmaVision San. ve Tic. A.Ş.to receive the “TSE COVID-19 Safe Production Certificate” 


The measures we have taken against the pandemic with the active participation of all our colleagues, which measures are being constantly developed, have thus also been approved by the Turkish Standards Institute and with 3 audits passed the TSE COVID-19 Safe Production Site Certification was maintained between June 2020 and June 2022.